Orion Corporation (Finland) holds 0 active US FDA Type II Drug Master Files and 29 inactive and has DMF or CEP filings on record for 19 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Orion Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/orion-corporation

Overview

Orion Corporation is a Finnish pharmaceutical company specializing in the discovery, development, and manufacturing of pharmaceuticals. It focuses on several therapeutic areas and produces both prescription medicines and self-care products.

Core services & business areas

Regulatory AffairsMarket AccessDistribution

Therapeutic areas

CNS (Central Nervous System)OncologyRespiratoryMen's HealthAnesthesiology

Active ingredients with DMF or CEP filings

Substances for which Orion Corporation holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Orion Corporation holds 0 active (29 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • DEXMEDETOMIDINEInactive1991-07-18
  • TRIAZOLAMInactive1991-06-26
  • FAVOXATE HCLInactive1989-01-16
  • TERFENADINEInactive1988-12-08
  • PENTOXIFYLLINEInactive1988-10-04
  • SELENIUM SULFIDEInactive1987-11-10
  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN FINLAND.Inactive1987-03-03
  • PRAZOSIN HCL DELTA-FORMInactive1987-02-18
  • PRAZOSIN HCL ALPHA-FORMInactive1987-02-18
  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MANKKAA PLANT.Inactive1987-01-26
  • TOLMETIN SODIUMInactive1986-12-19
  • MINOXIDILInactive1986-06-25
  • CHLORHEXIDINE DIHYDROCHLORIDE BP 80Inactive1986-03-19
  • BENZTROPINE MESYLATEInactive1986-01-30
  • RITODRINE HCLInactive1986-01-03
  • METHOCARBAMOLInactive1985-08-06
  • IMIPRAMINE HCL.Inactive1985-05-10
  • CARBAMAZEPINE USP XXInactive1984-12-27
  • CHLORHEXIDINE BASEInactive1984-12-13
  • SUCRALFATEInactive1984-06-25
  • CYCLOPHOSPHAMIDE 50 MG TABLETSInactive1984-03-23
  • IBUPROFENInactive1984-01-11
  • CHLORTHALIDONE USP XX AND BP 80Inactive1982-10-15
  • THIORIDAZINE HYDROCHLORIDEInactive1982-07-14
  • CHLORHEXIDINE ACETATE BP 80Inactive1981-06-15
  • CHLORHEXIDINE ACETATE, BPCInactive1978-10-10
  • GENERAL METHODS, FACILITIES, AND CONTROLSInactive1978-08-11
  • PERPHENAZINEInactive1978-07-21
  • CHLORHEXIDINE GLUCONATE SOLUTION BP 20%Inactive1978-06-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Orion Corporation in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Orion Corporation?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.